StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

PLXBullishEarningsnews
High materiality8/10

Protalix Q2 2026 results strengthen Elfabrio growth and cash runway

Aug 12, 2026, 6:54 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Profitability year-to-date, robust Elfabrio sales, milestone payments, and cash runway reduce downside and support upside from near-term results and IP/ pipeline milestones.

AI summary

What happened, with direct paths to the underlying reporting

Protalix reported Q2 2026 results showing improving top-line and profitability, with $19.8m in quarterly selling goods revenue and $53.6m year-to-date revenue, aided by Elfabrio sales and a $25m milestone from Chiesi. Net income for the period was positive and cash was $40.7m, supporting PRX-115 enrollment and the 2026 outlook.

  • Q2 2026 selling goods revenue: $19.8m; six months: $27.2m, up vs 2025.
  • Total 2026 revenue YTD: $53.6m, includes $25m milestone from Chiesi.
  • YTD net income: $22.1m; company profitability achieved year-to-date.
  • Cash, cash equivalents & short-term deposits: $40.7m as of 6/30/2026.
  • Elfabrio patent extension to 2035; PRX-115 patent issued 7/7/2026; 2026 guidance reaffirmed.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.